🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Chadi Nabhan

ORCID: 0000-0002-4316-7826
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 6 papers. Top paper: Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997–2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR).

7 citations

Shamia Hoque, Nancy F. Olivieri, Matthew A. Taylor, David M. Aboulafia, Courtney Lubaczewski +29 more

5 citations

Sonali M. Smith, Brad S. Kahl, Chadi Nabhan

2 citations

Sumimasa Nagai, Andrew C. Bennett, Shamia Hoque, Chadi Nabhan, Martin W. Schoen +18 more

23 citations

John R. Lozada, Nicholas A. Zorko, Andrew Elliott, Allison Makovec, Milan Radovich +18 more

N/A
0DataRank · unranked
0 citations

Kimberly Seymour, Stephanie L. Graff, Chadi Nabhan, Andrew Elliott, Sheldon L. Holder +1 more

11 citations

Pornlada Likasitwatanakul, Sachin Kumar Deshmukh, Sharon Wu, Jason J. Kwon, Eamon Toye +18 more